Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

227142

registered interest
date	12/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vale of York Clinical Commissioning Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much Vale of York Clinical Commissioning Group spent on managing provider contracts in 2013 and in each subsequent year.
tabling member constituency	York Central
tabling member printed	Sir Hugh Bayley
uin	227389
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>This information is not collected centrally.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/03/2015 17:39:31 answering member 3918 label Biography information for Jane Ellison
tabling member	385 label Biography information for Sir Hugh Bayley

227144

registered interest
date	12/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Abortion
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what powers he possesses to take action against abortion providers which fail to comply with his Department's interpretation of the Abortion Act 1967 as set out in the Guidance on the Requirements of the Abortion Act 1967.
tabling member constituency	Congleton
tabling member printed	Fiona Bruce
uin	227430
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>The Secretary of State for Health has powers under section 1(3) of the Abortion Act 1967 and these could be used in such circumstances.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/03/2015 17:28:46 answering member 3918 label Biography information for Jane Ellison
tabling member	3958 label Biography information for Fiona Bruce

227156

registered interest
date	12/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sexually Transmitted Infections: Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps (a) his Department and (b) Public Health England is taking to investigate the prevalence of the availability of antibiotics to treat sexually-transmitted infections via websites.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	227487
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>Pharmacies with premises in Great Britain, including on-line pharmacies, that are registered with the General Pharmaceutical Council must comply with the standards set by that Council. Pharmacists and pharmacy technicians registered with the Council and who work in any pharmacy must similarly comply with the standards of conduct, ethics and performance set by the Council including legal and professional requirements and accepted guidance on professional practice.</p><p> </p><p> </p><p> </p><p>Testing and treatment services, irrespective of how and where they are provided, should meet national standards recommended by the British Association for Sexual Health and HIV and Public Health England. Ultimately it is for doctors and other prescribers “to provide effective treatments based on the best available evidence” in accordance with guidance from the General Medical Council and other regulatory bodies.</p><p> </p><p> </p><p> </p><p>Any website found to be operating in breach of regulations governing the supply of medicines can be referred to Medicines and Healthcare products Regulatory Authority for consideration and further action.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227492 question first answered 17/03/2015 17:29:38 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

227163

registered interest
date	12/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Public Health England
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much Public Health England has spent on marketing campaigning in each year since it was established; and how much of that spending was on campaigns on mental health.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	227480
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>Public Health England (PHE) took over all the public health campaigns formerly run by the Department on 1 April 2013.</p><p> </p><p> </p><p> </p><p>Of PHE’s total social marketing budget of £30,565,000, the budget for mental health and wellbeing campaigns specifically was £205,000. However, other PHE led social marketing campaigns contribute to improving mental health and wellbeing, and therefore this should not be seen as the totality of social marketing spend on mental health and wellbeing by PHE.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/03/2015 17:32:29 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

227164

registered interest
date	12/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gonorrhoea
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that national best practice guidelines are adhered to in provision of treatment of gonorrhoea through online pharmacies.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	227492
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>Pharmacies with premises in Great Britain, including on-line pharmacies, that are registered with the General Pharmaceutical Council must comply with the standards set by that Council. Pharmacists and pharmacy technicians registered with the Council and who work in any pharmacy must similarly comply with the standards of conduct, ethics and performance set by the Council including legal and professional requirements and accepted guidance on professional practice.</p><p> </p><p> </p><p> </p><p>Testing and treatment services, irrespective of how and where they are provided, should meet national standards recommended by the British Association for Sexual Health and HIV and Public Health England. Ultimately it is for doctors and other prescribers “to provide effective treatments based on the best available evidence” in accordance with guidance from the General Medical Council and other regulatory bodies.</p><p> </p><p> </p><p> </p><p>Any website found to be operating in breach of regulations governing the supply of medicines can be referred to Medicines and Healthcare products Regulatory Authority for consideration and further action.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227487 question first answered 17/03/2015 17:29:38 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

226701

registered interest
date	11/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	University Hospitals Bristol NHS Foundation Trust
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 6 March 2015 to Question 225987, for what reasons the Answer states that a contract for University Hospital Bristol to deliver stereotactic radiosurgery (SRS) was transferred to NHS England in April 2013 when that hospital first acquired a gamma knife to deliver SRS in October 2013.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	227144
answer	answer is ministerial correction date of answer 16/03/2015 answer text <p>All existing contracts for stereotactic radiosurgery and stereotactic radiotherapy services, including that with University Hospital Bristol, were transferred to NHS England on 1 April 2013. Gamma Knife treatments started at University Hospital Bristol in October 2013, as there was an identified need for this provider to replace its existing equipment.</p><p> </p><p> </p><p> </p><p>NHS England intends to update the information contained within the <em>Stereotactic Radiosurgery and Radiotherapy Services - needs assessment and service review</em> to reflect the 2014-15 contract position as part of the work to review the results of the consultation on the future provision of stereotactic radiosurgery services.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227124 question first answered 16/03/2015 16:26:00 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

226703

registered interest
date	11/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	University Hospitals Bristol NHS Foundation Trust
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 6 March 2015 to Question 225987, which refers to there being a contract for stereotactic radiosurgery and stereotactic radiotherapy services (SRS) with University Hospital Bristol, for what reasons that hospital is listed as non-contracted and non-commissioned to deliver SRS in the NHS England document Stereotactic radiosurgery and radiotherapy services needs assessment and service review, published in November 2014.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	227124
answer	answer is ministerial correction date of answer 16/03/2015 answer text <p>All existing contracts for stereotactic radiosurgery and stereotactic radiotherapy services, including that with University Hospital Bristol, were transferred to NHS England on 1 April 2013. Gamma Knife treatments started at University Hospital Bristol in October 2013, as there was an identified need for this provider to replace its existing equipment.</p><p> </p><p> </p><p> </p><p>NHS England intends to update the information contained within the <em>Stereotactic Radiosurgery and Radiotherapy Services - needs assessment and service review</em> to reflect the 2014-15 contract position as part of the work to review the results of the consultation on the future provision of stereotactic radiosurgery services.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227144 question first answered 16/03/2015 16:26:00 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

226704

registered interest
date	11/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 25 February 2015 to Question 224828, what assessment he has made of the factors contributing to the reduction in NHS-funded IVF cycles from 2013 to 2014.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	227135
answer	answer is ministerial correction date of answer 16/03/2015 answer text <p>NHS England has made no assessment of the factors contributing to the difference between 22,340 National Health Service-funded cycles of in vitro fertilisation in 2013 and 22,238 cycles in 2014, a reduction of less than 0.5%.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 16/03/2015 17:46:12 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

226714

registered interest
date	11/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cardiovascular Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when his Department plans to publish an update on its progress on the ambitions and actions in its Cardiovascular Disease Outcomes Strategy, published in March 2013.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	227372
answer	answer is ministerial correction date of answer 16/03/2015 answer text <p>It is for NHS England, working with Public Health England (PHE) and other stakeholders, to implement the actions set out in the Cardiovascular Disease (CVD) Outcomes Strategy.</p><p> </p><p> </p><p> </p><p>NHS England hosts a CVD outcomes collaborative which brings together the relevant National Clinical Directors, the main relevant national charities, NHS Improving Quality, the National CVD Intelligence Network, PHE and the Department. This collaborative continues to coordinate delivery of the work which was initiated in the CVD Outcomes Strategy. NHS England advises it has no current plans to publish a formal update on progress in implementing the strategy.</p><p> </p><p> </p><p> </p><p>The strategy recommended that the National Clinical Director for Heart Disease should work with stakeholders to develop and spread good practice in relation to familial hypercholesterolemia (FH) and a number of strategic clinical networks are now prioritising FH detection. In addition, NHS England is considering with stakeholders how a FH database could be established. However, increasing FH diagnosis rates to 50% was not a recommendation in the strategy.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227371 question first answered 16/03/2015 17:19:39 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy

226720

registered interest
date	11/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cholesterol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of when the ambition in his Department's Cardiovascular Disease Outcomes Strategy, published in March 2013, to bring the total diagnoses of familial hypercholesterolaemia to 50 per cent, will be met.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	227371
answer	answer is ministerial correction date of answer 16/03/2015 answer text <p>It is for NHS England, working with Public Health England (PHE) and other stakeholders, to implement the actions set out in the Cardiovascular Disease (CVD) Outcomes Strategy.</p><p> </p><p> </p><p> </p><p>NHS England hosts a CVD outcomes collaborative which brings together the relevant National Clinical Directors, the main relevant national charities, NHS Improving Quality, the National CVD Intelligence Network, PHE and the Department. This collaborative continues to coordinate delivery of the work which was initiated in the CVD Outcomes Strategy. NHS England advises it has no current plans to publish a formal update on progress in implementing the strategy.</p><p> </p><p> </p><p> </p><p>The strategy recommended that the National Clinical Director for Heart Disease should work with stakeholders to develop and spread good practice in relation to familial hypercholesterolemia (FH) and a number of strategic clinical networks are now prioritising FH detection. In addition, NHS England is considering with stakeholders how a FH database could be established. However, increasing FH diagnosis rates to 50% was not a recommendation in the strategy.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227372 question first answered 16/03/2015 17:19:39 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy